Functional interaction between the SH2 domain of Fyn and tyrosine 324 of hamster polyomavirus middle-T antigen

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 199-206

  Dunant, Nicolas M ^a   Messerschmitt, Anja S ^a   Ballmer Hofer, Kurt ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TYROSINE; VIRUS MIDDLE T ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL TRANSFORMATION; GENE MUTATION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0031060111     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.199-206.1997     Document Type: Article

References (49)

1. Brizuela, L., L. M. Olcese, and S. A. Courtneidge. 1994. Transformation by middle T antigens. Semin. Virol. 5:381-389.
2. Brizuela, L., E. T. Ulug, M. A. Jones, and S. A. Courtneidge. 1995. Induction of interleukin-2 transcription by the hamster polyomavirus middle T antigen: a role for Fyn in T cell signal transduction. Eur. J. Immunol. 25:385-393.
3. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
4. c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen. J. Virol. 65:170-179.
5. Cheng, S. H., P. C. Espino, J. Marshall, R. Harvey, and A. E. Smith. 1990. Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex. Mol. Cell. Biol. 10:5569-5574.
6. c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J. 7:3845-3855.
7. c-src: implications for regulation. Science 231:1431-1434.
8. Courtneidge, S. A., L. Goutebroze, A. Cartwright, A. Heber, S. Scherneck, and J. Feunteun. 1991. Identification and characterization of the hamster polyomavirus middle-T antigen. J. Virol. 65:3301-3308.
9. Courtneidge, S. A., and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303: 435-439.
10. Cuzin, P. 1984. The polyoma virus oncogenes. Biochim. Biophys. Acta 781: 193-204.
11. Delmas, V., C. Bastien, S. Scherneck, and J. Feunteun. 1985. A new member of the polyomavirus family: the hamster papovavirus complete nucleotide sequence and transformation properties. EMBO J. 4:1279-1286.
12. Dilworth, S. M. 1995. Polyoma virus middle T antigen: meddler or mimic? Trends Microbiol. 3:31-35.
13. Dilworth, S. M., C. E. Brewster, M. D. Jones, L. Lanfrancone, G. Pelicci, and P. G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of She. Nature 367:87-90.
14. c-src or protein phosphatase 2A by polyomavirus middle-T antigen. J. Virol. 67:2235-2244.
15. Dunant, N. M., M. Senften, and K. Ballmer-Hofer. 1996. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases. J. Virol. 70:1323-1330.
16. Goutebroze, L., and J. Feunteun. 1992. Transformation by hamster polyomavirus: identification and functional analysis of the early genes. J. Virol. 66:2495-2504.
17. Graffi, A., E. Bender, T. Schramm, W. Kuhn, and F. Schneiders. 1969. Induction of transmissible lymphomas in Syrian hamsters by application of DNA from viral hamster papovavirus-induced tumors and by cell-free filtrates from human tumors. Med. Sci. 64:1172-1175.
18. IS. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
19. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
20. c-src with polyoma virus middle-T antigen abrogating mitosis-specific activation. Nature 350:431-433.
21. Kaplan, D. R., M. Whitman, B. S. Schaffhausen, D. C. Pallas, M. White, L. Cantley, and T. M. Roberts. 1987. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021-1029.
22. Kiefer, F., S. A. Courtneidge, and E. F. Wagner. 1994. Oncogenic properties of the middle T antigens of polyomaviruses. Adv. Cancer Res. 64:125-157.
23. Kornbluth, S., M. Sudol, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature 325:171-173.
24. fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells. EMBO J. 7:3837-3844.
25. Liu, X., S. R. Brodeur, G. Gish, S. Zhou, L. C. Cantley, A. P. Laudano, and T. Pawson. 1993. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene 8:1119-1126.
26. c-src . J. Virol. 61:285-292.
27. Messerschmitt, A., C. Disela, S. Dilworth, A. G. Marti, and K. Ballmer-Hofer. 1996. Polyomavirus middle-T antigen lacking a membrane anchor sequence accumulates in the nucleus. J. Gen. Virol. 77:17-26.
28. c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors. Oncogene 4:1433-1439.
29. Okada, M., S. Nada, Y. Yamanashi, T. Yamamoto, and H. Nakagawa. 1991. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266:24249-24252.
30. Pallas, D. C., H. Fu, L. C. Haehnel, W. Weller, R. J. Collier, and T. M. Roberts. 1994. Association of polyomavirus middle tumor antigen with 14- 3-3 proteins. Science 265:535-537.
31. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
32. Pawson, T. 1994. SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64:87-110.
33. Ferez, L., A. Paasinen, B. Schnierle, S. Kaech, M. Senften, and K. Ballmer-Hofer. 1993. Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation. Proc. Natl. Acad. Sci. USA 90:8113-8117.
34. Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-1161.
35. Resh, M. D. 1994. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76:411-413.
36. Roche, S., S. Fumagalli, and S. A. Courtneidge. 1995. Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science 269:1567-1569.
37. c-src. Proc. Natl. Acad. Sci. USA 88:10696-10700.
38. Semba, K., M. Nishizawa, N. Miyajima, M. C. Yoshida, J. Sukegawa, M. Sasaki, T. Yamamoto, and K. Toyoshima. 1986. yes-related protooncogene, syn, belongs to the protein-lyrosine kinase family. Proc. Natl. Acad. Sci. USA 83:5459-5463.
39. Shaw, A. S., K. E. Amrein, C. Hammond, D. F. Stern, B. M. Sefton, and J. K. Rose. 1989. The lck tyrosine protein kinase interacts with the cyloplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell 59:627-636.
40. Songyang, Z., S. E. Sheolson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
41. Stein, P. L., H. Vogel, and P. Soriano. 1994. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8:1999-2007.
42. Su, W., W. Liu, B. S. Schaffhausen, and T. M. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270:12331-12334.
43. Superti Furga, G., S. Fumagalli, M. Koegl, S. A. Courtneidge, and G. Draetta. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12:2625-2634.
44. Tooze, J. 1980. DNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Treisman, R., U. Novak, J. Favaloro, and R. Kamen. 1981. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 292:595-600.
46. Urich, M., M. Y. El Shemerly, D. Besser, Y. Nagamine, and K. Ballmer-Hofer. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
47. Walter, G., R. Ruediger, C. Slaughter, and M. Mumby. 1990. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:2521-2525.
48. Whitman, M., D. K. Kaplan, B. S. Schaffhausen, L. Cantley, and T. M. Roberts. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-242.
49. Zhou, S., K. L. Carraway, M. J. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, and C. Eng. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539.